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Laboratory-Acquired Meningococcal Disease -United States, 2000
Neisseria meningitidis is a leading cause of bacterial meningitis and sepsis among older children and young adults in the United States. N. meningitidis usually is transmitted through close contact with aerosols or secretions from the human nasopharynx. Although N. meningitidis is regularly isolated in clinical laboratories, it has infrequently been reported as a cause of laboratory-acquired infection. This report describes two probable cases of fatal laboratory-acquired meningococcal disease and the results of an inquiry to identify previously unreported cases. The findings indicate that N. meningitidis isolates pose a risk for microbiologists and should be handled in a manner that minimizes risk for exposure to aerosols or droplets.
Case Reports
Case 1. On July 15, 2000, an Alabama microbiologist aged 35 years presented to the emergency department of hospital A with acute onset of generalized malaise, fever, and diffuse myalgias. The patient was given a prescription for oral antibiotics and released. On July 16, the patient returned to hospital A, became tachycardic and hypotensive, and died 3 hours later. Blood cultures were positive for N. meningitidis serogroup C. Three days before the onset of symptoms, the patient had prepared a Gram's stain from the blood culture of a patient who was subsequently shown to have meningococcal disease; the microbiologist also had handled and subcultured agar plates containing cerebrospinal fluid (CSF) cultures of N. meningitidis serogroup C from the same patient. Co-workers reported that in the laboratory, aspiration of materials from blood culture bottles was performed at the open laboratory bench; biosafety cabinets, eye protection, or masks were not used routinely for this procedure. Results of pulsedfield gel electrophoresis (PFGE) and multilocus enzyme electrophoresis (MEE) testing at CDC indicated that the two isolates were indistinguishable. The laboratory at hospital A infrequently processed isolates of N. meningitidis and had not processed another meningococcal isolate during the previous 4 years.
Case 2. On December 24, 2000, a Michigan microbiologist aged 52 years had acute onset of sore throat, vomiting, headache, and fever; by December 25, the patient had developed a petechial rash on both legs, which quickly evolved to widespread purpura. The patient presented to the emergency department of hospital B and died later that day of overwhelming sepsis. Blood cultures were positive for N. meningitidis serogroup C. The patient was a microbiologist in the state public health laboratory and had worked on several N. meningitidis serogroup C isolates during the 2 weeks before becoming ill. That laboratory had handled a median of four meningococcal isolates per month (range: 0-11) during the previous 4 years. Co-workers reported that the patient had performed slide agglutination testing and recorded colonial morphology using typical biosafety level 2 (BSL 2) precautions; this did not entail the use of a biosafety cabinet. PFGE was performed at the state public health laboratory and at CDC on all four specimens handled by the microbiologist; results of this testing indicated that the isolates from the patient and from one of the recently handled laboratory samples were indistinguishable. To detect additional cases, on November 11, 2000, a request for information was posted on selected electronic mail discussion groups (i.e., listservs) to members of several infectious disease, microbiology, and infection control professional organizations. A probable case of laboratory-acquired meningococcal disease was defined as confirmed or probable meningococcal disease (1) in a laboratory scientist who had had occupational exposure to a N. meningitidis isolate during the 14 days before onset of illness and who had illness with a serogroup that matched the source isolate. In addition to the two cases described in this report, CDC received an additional 14 reports of probable laboratory-acquired meningococcal disease worldwide during the preceding 15 years; six cases occurred in the United States during 1996-2001. The source isolates from five of these six U.S. cases were from either blood or CSF; the source of the sixth isolate could not be definitively determined but was most likely CSF or middle ear fluid. Of these 16 previously unreported cases, nine (56%) were caused by N. meningitidis serogroup B, and seven (44%) were caused by serogroup C; eight cases (50%) were fatal (three from serogroup B and five from serogroup C). Casefatality rates did not differ significantly by serogroups (serogroup C: 71%; serogroup B: 33%; p=0.16). In the 10 cases for which data were available, a median of 4 days (range: 2-10 days) passed between handling the source isolate and symptom onset. Procedures performed on the 16 source isolates included reading plates (50%), making subcultures on agar plates (50%), and performing serogroup identification at the bench (38%). In 15 of the 16 cases, the laboratory reportedly did not perform procedures within a biosafety cabinet. All 16 cases occurred among workers in the microbiology section of the laboratory; no cases were reported among workers in hematology, chemistry, or pathology.
Although the exact mechanism of transmission in the laboratory setting is unclear, use of a biosafety cabinet during manipulation of sterile site isolates of N. meningitidis would ensure protection. Alternative methods of protection (e.g., splash guards and masks) from droplets and aerosols require additional assessment. If a biosafety cabinet or other means of protection is unavailable, manipulation of these isolates should be minimized, and workers should consider sending specimens to laboratories possessing this equipment. Education of microbiologists and strict adherence to these safety precautions when manipulating meningococcal isolates should further minimize the risk for infection. To address these safety issues, the governing bodies of organizations responsible for setting policy for laboratory safety will be reassessing current guidelines about the handling of N. meningitidis.
Although primary prevention should focus on laboratory safety, laboratory workers also should make informed decisions about vaccination. The quadrivalent meningococcal polysaccharide vaccine, which includes serogroups A, C, Y, and W-135, will decrease but not eliminate the risk for infection (6) . Research and industrial laboratory scientists who are exposed routinely to N. meningitidis in solutions that might be aerosolized also should consider vaccination (6) (7) (8) . In addition, vaccination might be used as an adjunctive measure by microbiologists in clinical laboratories.
Laboratory scientists with percutaneous exposure to an invasive N. meningitidis isolate from a sterile site should receive treatment with penicillin; those with known mucosal exposure should receive antimicrobial chemoprophylaxis (6) ( Table 1) . Microbiologists who manipulate invasive N. meningitidis isolates in a manner that could induce aerosolization or droplet formation (including plating, † Not recommended for pregnant women because the drug is teratogenic in laboratory animals. Because the reliability of oral contraceptives may be affected by rifampin therapy, consideration should be given to using alternative contraceptive measures while rifampin is being administered. § Not generally recommended for persons aged <18 years or for pregnant and lactating women because the drug causes cartilage damage in immature laboratory animals. However, ciprofloxacin can be used for chemoprophylaxis of children when no acceptable alternative therapy is available.
Populations Receiving Optimally Fluoridated Public Drinking Water -United States, 2000
Dental caries (i.e., tooth decay) is a transmissible, multifactor disease that affects 50% of children aged 5-9 years, 67% of adolescents aged 12-17 years (1), and 94% of adults aged >18 years (2) in the United States. During the second half of the 20th century (3), a major decline in the prevalence and severity of dental caries resulted from the identification of fluoride as an effective method of preventing caries. Fluoridation of the public water supply is the most equitable, costeffective, and cost-saving method of delivering fluoride to the community (4, 5) . In the United States during 2000, approximately 162 million persons (65.8% of the population served by public water systems) received optimally fluoridated water compared with 144 million (62.1%) in 1992 (6) . This report presents state-specific data on the status of water fluoridation in the United States and describes a new surveillance system designed to routinely produce state and national data to monitor fluoridation in the public water supply. The results of this report indicate slow progress toward increasing access to optimally fluoridated water for persons using public water systems. Data from the new surveillance system can heighten public awareness of this effective caries prevention measure and can be used to identify areas where additional health promotion efforts are needed.
The 2000 and 2010 national health goals include objectives (13.9 and 21.9, respectively) (7, 8) to increase the 1989 and 1992 national baseline fluoridation levels (61% and 62%, respectively) (6,9) to 75% of the U.S. population served by community water systems that receive water with optimal levels of fluoride (0.7-1.2 ppm depending on the average maximum daily air temperature of the area). The U.S. Environmental Protection Agency (EPA) does not regulate the addition of fluoride to water, and EPA's Safe Drinking Water Information System (SDWIS) actively tracks fluoride concentrations only in water systems with naturally occurring fluoride levels above the established regulatory limits (>2.0 ppm).
During 1998-2000, CDC developed the Water Fluoridation Reporting System (WFRS), a surveillance database that included CDC's 1992 water fluoridation census (6) and EPA's SDWIS. To ensure that initial data were accurate and complete, in 2000, CDC sent state-specific reports generated from WFRS to the oral health contact at each state health agency for review; updated information was returned, and nonrespondents were contacted through telephone calls and electronic messages. In July 2001, each state received its preliminary public water system data and was asked to submit corrections. Alabama, California, Kansas, Louisiana, Montana, Rhode Island, Texas, and Wyoming had not updated their data by September 1, 2001 ; therefore, existing WFRS data were used in this report.
Fluoridation percentages were determined by dividing the number of persons using public water systems with fluoride levels considered optimal (naturally occurring and adjusted) for the state by the total population of the state served by public water systems. When the population served by public water systems exceeded the 2000 population census for that state, the state census was used as the population using the public water supplies. This might occur as a result of the methods used by water systems to estimate the population served. These states were Alabama, Hawaii, Louisiana, Massachusetts, Missouri, Utah, and Wyoming. Editorial Note: WFRS data indicate that during the 1990s, the estimated proportion of the U.S. population using public water supplies that maintained optimally fluoridated water increased from 62.1% to 65.8%. This modest progress occurred as the result of substantial increases in coverage in a few states and, in some instances, because several large metropolitan areas commenced fluoridation (e.g., Clark County [Las Vegas], Nevada; Los Angeles and Sacramento, California; and Manchester, New Hampshire).
The findings in this report are subject to at least three limitations. First, nonresponses might have affected the accuracy of some states' final water fluoridation percentages by not accounting for changes in status. Second, use of the 2000 U.S. census data as the denominator for calculating water fluoridation percentages in seven states might have resulted in the percentages being underestimated because, in most states, the number of persons using public water systems was probably less than the 2000 U.S. census population. Finally, three states (Kentucky, Rhode Island, and South Dakota) reported their 1992 fluoridation rates as 100%; in these states, the apparent decrease from 1992 to 2000 in the percentage of persons using public water supplies receiving optimally fluoridated water represents an error correction in reporting methods rather than a true decrease.
WFRS will become an increasingly valuable tool for monitoring state and annually updating national water fluoridation data as more users register and routinely participate in entering data and receiving reports. WFRS updates and reports will assist states in monitoring the extent and consistency of water fluoridation. During 2002, CDC will provide online information on water fluoridation for states that update their data electronically.
Although the new WFRS online site might facilitate public knowledge about optimally fluoridated water, efforts to convince jurisdictions to provide such water must address 1) the perception by some scientists, policymakers, and members of the public that dental caries is no longer a public health problem or that fluoridation is no longer necessary or effective; 2) the often complex political process involved in adopting water fluoridation; and 3) unsubstantiated claims by opponents of water fluoridation about its alleged adverse health effects (10) . To reach the goal of 75% of the public water drinking population supplied with optimally fluoridated water, policymakers and public health officials at the federal, state, and local levels will need to devise new promotion and funding approaches to gain support for this prevention measure. 
Socioeconomic Status of Women with Diabetes -United States, 2000
Persons whose socioeconomic status is low have poorer health than other persons (1, 2) and are less likely to have adequate access to care or to receive high-quality clinical and prevention care services (3). In the United States, diabetes is a potentially debilitating disease that is increasing in prevalence (4); however, little is known about the socioeconomic status of persons with diabetes (5-7). Women account for approximately 52% of all persons aged >20 years with diabetes (4). To assess the socioeconomic status of women with diabetes, CDC analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS), which indicated that the socioeconomic status of women with diabetes in 2000 was markedly lower than that of women without diabetes. Efforts should be focused to understand the impact of socioeconomic conditions on the health and quality of care of women with diabetes.
BRFSS is a state-based, random-digit-dialed telephone survey of the noninstitutionalized U.S. population aged >18 years. In 2000, the median state-specific response rate was 48.9% (range: 28.8%-71.8%) (CDC, unpublished data, 2001). Persons with diabetes were identified if they answered "yes" to the question, "Have you ever been told by a doctor that you have diabetes?" Women who answered "no" and those who had been told they had diabetes only during pregnancy were considered not to have diabetes. Data on level of education and annual household income were used to assess socioeconomic status; marital status, size of household, and employment status were used as indicators of living arrangements; and household size was derived by adding the number of adults and number of children aged <17 years. A woman was classified as having low socioeconomic status if she did not complete high school or resided in a household with an annual income of <$25,000.
State-specific data were aggregated and weighted to reflect age, sex, and racial/ethnic distribution, and chi-square tests were used to test all univariate associations. Because many persons aged 18-24 years have not completed their education, socioeconomic status was evaluated only for women aged >25 years. Multivariate logistic regression analysis was used to examine the relation between having diabetes and not completing high school or living in a low-income household, with control made for age, race/ethnicity, and living arrangements. The models then were used to calculate adjusted percentages using the distributions of female respondents aged >25 years in the total population. All analyses were conducted using SASv8 software with SUDAAN to estimate standard errors.
Of the 109,680 women who participated in the 2000 BRFSS survey, 6,835 (6.3%) had been told by a doctor that they had diabetes (mean age at diagnosis: 48.8 years). Women with diabetes were more likely than women without diabetes to be aged >45 years; nonwhite; divorced, separated, or widowed; living alone; retired; or unable to work (Table 1) .
Among women aged >25 years, the percentage with diabetes who had not completed high school (27.7%; 95% confidence interval [CI]=25.7%-29.7%) was more than twice that of women without diabetes who had not completed high school (12.2%; 95% CI=11.8%-12.6%) ( Table 2 ). Among women with diabetes, 20.5% (95% CI=18.0%-25.3%) of those aged 25-44 years had not completed high school, compared with 34.3% (95% CI=31.4%-37.2%) of those aged >65 years. Among women without diabetes, 9.8% (95% CI=9.2%-10.3%) of those aged 25-44 years had not completed high school, compared with 20.5% (95% CI=19.5%-21.5%) of those aged >65 years. After multivariate adjustment, a low level of formal education remained significantly more common among women with diabetes than among those without diabetes. Editorial Note: The findings in this report indicate that the socioeconomic status of women with diabetes is lower than that of women without diabetes and confirm the findings of the 1989 National Health Interview Survey (NHIS) (5). In 2000, at least one in four women with diabetes aged >25 years had a low level of formal education, and 40% lived in lowincome households. Women with diabetes were more likely to have a low socioeconomic status independent of living arrangements (i.e., marital status, size of household, and employment status). Attaining a higher educational level might influence decision-making, and persons with a higher income might have better access to health care, higher living standards, and other material benefits that have a positive impact on health. Although socioeconomic status might be influenced adversely by factors related to having diabetes (e.g., being unemployed or retiring early), most women with diabetes in this survey were diagnosed long after they had completed their education. BRFSS estimates suggest that the low socioeconomic status of many women with diabetes might compromise their ability to benefit from treatments that might reduce their risks for complications and premature death. Programs designed to meet the needs of women with diabetes should take socioeconomic status into account to assure that women benefit from the interventions. Performance should be carefully evaluated to assess program effectiveness and identify areas for improvement. The findings in this report are subject to at least three limitations. First, the low median response rate suggests the potential for participation bias. Second, all data were selfreported and might be subject to recall bias. Finally, the level of low socioeconomic status (i.e., household income <$25,000) among women with diabetes might be underestimated because 21% of women with diabetes declined to - -249  192  118  143  10  6  Del. - - 12  19  5  8  2  -PACIFIC  2  9  --235  265  71  143  16  13  Wash.  ----7  5  2  5  --Oreg.  2  ---20  1  17  3  6  1  Calif.  -8  --208  248  52  131  10  12  Alaska  -----10  - - -160  178  Ky.  ------18  31  Tenn.  2  1  ----46  34  Ala.  ------60  76  Miss. - References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites.
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state their income; these nonrespondents were more likely to be elderly, Hispanic, widowed, retired, or not to have completed high school (i.e., to belong to groups that are frequently low income). CDC has initiated activities that focus on the needs of women with diabetes. CDC's "Diabetes and Women's Health Across the Life Stages: A Public Health Perspective" analyzes the epidemiologic, social, and environmental dimensions of women and diabetes and discusses public health implications (8) . CDC, the American Diabetes Association, the American Public Health Association, and the Association of State and Territorial Health Officials are developing a National Public Health Action Plan for Diabetes and Women. CDC is sponsoring Translating Research into Action for Diabetes (TRIAD), a 5-year prospective study of the quality of diabetes care, costs, and outcomes in managed-care settings that will examine the effects of socioeconomic status on health and quality of care. Finally, CDC is encouraging increased focus on women with diabetes through the National Diabetes Education Program, a collaborative effort with the National Institutes of Health to promote early diagnosis and improvement of the treatment and outcomes for persons with diabetes (available at http:// www.cdc.gov/diabetes/projects/ndeps.htm); Racial and Ethnic Approaches to Community Health (REACH) 2010, a program aimed at eliminating disparities in the health status of ethnic minorities (available at http://www.cdc.gov/ reach2010), and state-based diabetes control programs.
The low socioeconomic status of many women with diabetes poses challenges to public health practitioners. As the prevalence of diabetes continues to increase, continued and creative efforts will be needed to gain greater understanding of how socioeconomic status affects the health of women with diabetes.
